These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38839666)

  • 21. Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone.
    Salido-Guadarrama AI; Morales-Montor JG; Rangel-Escareño C; Langley E; Peralta-Zaragoza O; Cruz Colin JL; Rodriguez-Dorantes M
    Mol Med Rep; 2016 Jun; 13(6):4549-60. PubMed ID: 27081843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Challenges in Cancer Biomarker Discovery Exemplified by the Identification of Diagnostic MicroRNAs in Prostate Tissues.
    Ambrozkiewicz F; Karczmarski J; Kulecka M; Paziewska A; Cybulska M; Szymanski M; Dobruch J; Antoniewicz A; Mikula M; Ostrowski J
    Biomed Res Int; 2020; 2020():9086829. PubMed ID: 32462034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of circulating miRNAs: comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients.
    Endzeliņš E; Berger A; Melne V; Bajo-Santos C; Soboļevska K; Ābols A; Rodriguez M; Šantare D; Rudņickiha A; Lietuvietis V; Llorente A; Linē A
    BMC Cancer; 2017 Nov; 17(1):730. PubMed ID: 29121858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum Levels of miR-223-3p and miR-223-5p in Prostate Diseases.
    Dülgeroğlu Y; Eroğlu O
    Microrna; 2020; 9(4):303-309. PubMed ID: 33155933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extent of lymph node dissection improves survival in prostate cancer patients treated with radical prostatectomy without lymph node invasion.
    Preisser F; Bandini M; Marchioni M; Nazzani S; Tian Z; Pompe RS; Fossati N; Briganti A; Saad F; Shariat SF; Heinzer H; Huland H; Graefen M; Tilki D; Karakiewicz PI
    Prostate; 2018 May; 78(6):469-475. PubMed ID: 29460290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection.
    Gacci M; Schiavina R; Lanciotti M; Masieri L; Serni S; Vagnoni V; Abdollah F; Carini M; Martorana G; Montorsi F
    Urol Int; 2013; 90(3):277-82. PubMed ID: 23296120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Extracellular Vesicle Isolation Methods on Downstream Mirna Analysis in Semen: A Comparative Study.
    Mercadal M; Herrero C; López-Rodrigo O; Castells M; de la Fuente A; Vigués F; Bassas L; Larriba S
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32824915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Salivary extracellular vesicle-associated miRNAs as potential biomarkers in oral squamous cell carcinoma.
    Gai C; Camussi F; Broccoletti R; Gambino A; Cabras M; Molinaro L; Carossa S; Camussi G; Arduino PG
    BMC Cancer; 2018 Apr; 18(1):439. PubMed ID: 29669525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colorectal cancer cell-derived extracellular vesicles transfer miR-221-3p to promote endothelial cell angiogenesis via targeting suppressor of cytokine signaling 3.
    Dokhanchi M; Pakravan K; Zareian S; Hussen BM; Farid M; Razmara E; Mossahebi-Mohammadi M; Cho WC; Babashah S
    Life Sci; 2021 Nov; 285():119937. PubMed ID: 34508764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obesity strongly predicts clinically undetected multiple lymph node metastases in intermediate- and high-risk prostate cancer patients who underwent robot assisted radical prostatectomy and extended lymph node dissection.
    Tafuri A; Amigoni N; Rizzetto R; Sebben M; Shakir A; Gozzo A; Odorizzi K; De Michele M; Gallina S; Bianchi A; Ornaghi P; Brunelli M; De Marco V; Verratti V; Migliorini F; Cerruto MA; Artibani W; Antonelli A; Porcaro AB
    Int Urol Nephrol; 2020 Nov; 52(11):2097-2105. PubMed ID: 32607958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical significance of miRNA host gene promoter methylation in prostate cancer.
    Daniunaite K; Dubikaityte M; Gibas P; Bakavicius A; Rimantas Lazutka J; Ulys A; Jankevicius F; Jarmalaite S
    Hum Mol Genet; 2017 Jul; 26(13):2451-2461. PubMed ID: 28398479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High body mass index predicts multiple prostate cancer lymph node metastases after radical prostatectomy and extended pelvic lymph node dissection.
    Porcaro AB; Tafuri A; Sebben M; Processali T; Pirozzi M; Amigoni N; Rizzetto R; Shakir A; Cerruto MA; Brunelli M; Siracusano S; Artibani W
    Asian J Androl; 2020; 22(3):323-329. PubMed ID: 31347517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate-specific antigen associates with extensive lymph node invasion in high-risk prostate cancer.
    Porcaro AB; Corsi P; Inverardi D; Sebben M; Tafuri A; Processali T; Mattevi D; De Marchi D; Pirozzi M; Cerruto MA; Amigoni N; Rizzetto R; Brunelli M; Siracusano S; Artibani W
    Tumori; 2018 Aug; 104(4):307-311. PubMed ID: 29714659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The utility of urine-circulating miRNAs for detection of prostate cancer.
    Stuopelyte K; Daniunaite K; Bakavicius A; Lazutka JR; Jankevicius F; Jarmalaite S
    Br J Cancer; 2016 Sep; 115(6):707-15. PubMed ID: 27490805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-21-5p, miR-141-3p, and miR-205-5p levels in urine-promising biomarkers for the identification of prostate and bladder cancer.
    Ghorbanmehr N; Gharbi S; Korsching E; Tavallaei M; Einollahi B; Mowla SJ
    Prostate; 2019 Jan; 79(1):88-95. PubMed ID: 30194772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SIV Infection Regulates Compartmentalization of Circulating Blood Plasma miRNAs within Extracellular Vesicles (EVs) and Extracellular Condensates (ECs) and Decreases EV-Associated miRNA-128.
    Kopcho S; McDew-White M; Naushad W; Mohan M; Okeoma CM
    Viruses; 2023 Feb; 15(3):. PubMed ID: 36992331
    [No Abstract]   [Full Text] [Related]  

  • 37. miR-10a-5p and miR-29b-3p as Extracellular Vesicle-Associated Prostate Cancer Detection Markers.
    Worst TS; Previti C; Nitschke K; Diessl N; Gross JC; Hoffmann L; Frey L; Thomas V; Kahlert C; Bieback K; Crigna AT; Fricke F; Porubsky S; Westhoff N; Hardenberg JV; Nuhn P; Erben P; Michel MS; Boutros M
    Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31877768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and internal validation of a novel model and markers to identify the candidates for lymph node metastasis in patients with prostate cancer.
    Cao HM; Wan Z; Wu Y; Wang HY; Guan C
    Medicine (Baltimore); 2019 Jul; 98(30):e16534. PubMed ID: 31348270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identifying candidates for super-extended staging pelvic lymph node dissection among patients with high-risk prostate cancer.
    Gandaglia G; Zaffuto E; Fossati N; Bandini M; Suardi N; Mazzone E; Dell'Oglio P; Stabile A; Freschi M; Montorsi F; Briganti A
    BJU Int; 2018 Mar; 121(3):421-427. PubMed ID: 29063734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool.
    Gandaglia G; Barletta F; Robesti D; Scuderi S; Rajwa P; Gomez Rivas J; Ibanez L; Soeterik TFW; Bianchi L; Afferi L; Kesch C; Darr C; Guo H; Zhuang J; Zattoni F; Fendler W; Marra G; Stabile A; Amparore D; Huebner NA; Giesen A; Joniau S; Schiavina R; Brunocilla E; Mattei A; Dal Moro F; Sierra JM; Porpiglia F; Picchio M; van den Bergh R; Shariat SF; Montorsi F; Briganti A
    Eur Urol Oncol; 2023 Dec; 6(6):543-552. PubMed ID: 37270378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.